Latest News

Key Insights BJ's Restaurants' estimated fair value is US$32.04 based on 2 Stage Free Cash Flow to Equity With US$37.20...

We feel now is a pretty good time to analyse Metacon AB (publ)'s ( STO:META ) business as it appears the company may be...

Mayfield Group Holdings (ASX:MYG) just wrapped up a series of follow-on equity offerings, raising over A$30 million. This fresh capital injection has investors weighing the potential impact on the company’s outlook and future initiatives. See our latest analysis for Mayfield Group Holdings. The recent equity raise comes against the backdrop of remarkable momentum for Mayfield Group Holdings. While the past day’s share price return was flat, the stock soared 15% over the past week and...

Tokyo Seimitsu (TSE:7729) shook up investors with a fresh revision to its full-year guidance, cutting net profit and earnings per share projections and announcing lower dividends for both interim and year-end periods. The move highlights how added costs tied to product countermeasures are affecting overall profitability. At the same time, sales forecasts have been raised due to unexpectedly strong orders in the SPE business. See our latest analysis for Tokyo Seimitsu. Tokyo Seimitsu’s recent...

Amphenol (APH) stock has been on the radar for many investors, driven by its steady growth figures over the past year. The company’s strong financial trajectory continues to spark interest among those following the tech hardware sector. See our latest analysis for Amphenol. After a rapid climb throughout the year, Amphenol’s share price currently sits at $135.25 following a recent dip. This marks a notable 96% year-to-date share price return. The momentum has been especially pronounced over...

Wondering if Teledyne Technologies is fairly valued or a hidden gem? You are not alone, especially if you follow stocks with strong long-term potential and quality fundamentals. Teledyne’s stock has shown resilience, edging up 10.4% year-to-date despite a recent dip of 11.6% over the past month that has caught some investors’ attention. Recent headlines highlight Teledyne’s continued investment in sensor and instrumentation technology, as well as high-profile contract wins that strengthen...

Wondering if PayPal’s stock is actually a bargain, or if it’s still playing catch-up? You’re not alone. The real answer might be hiding in plain sight. The share price has slipped recently, dropping 1.4% over the past week and 5.5% in the last month. It’s down nearly 24% since the start of the year. Much of this volatility has played out as the market digests shifting sentiment around digital payments. Headlines have highlighted intense competition from fintech newcomers and scrutiny over...

Guardant Health (GH) shares have seen significant movement lately, catching the attention of investors interested in innovative healthcare stocks. Over the past month, the stock has surged around 50 percent, reflecting a busy stretch for the genomics firm. See our latest analysis for Guardant Health. Guardant Health’s recent rally caps off an extraordinary year, as the company’s 1-year total shareholder return has soared 211.6 percent. The strong 30-day share price return hints at growing...

Itoham Yonekyu Holdings (TSE:2296) has announced an upward revision to its earnings guidance for the year ending March 2026. The company highlights expectations for higher sales, operating profit, and net income compared to previous forecasts. See our latest analysis for Itoham Yonekyu Holdings. Following the upward revision to its earnings forecast, Itoham Yonekyu Holdings has kept up its momentum with a reassuring dividend announcement and steady board activity. The company’s recent moves...

Hydro One (TSX:H) just made headlines with its new earnings guidance, projecting annual earnings per share growth of 6% to 8% through 2027. This update was released together with a strong performance in its latest quarterly results. See our latest analysis for Hydro One. Hydro One’s upbeat forecasts and solid Q3 results have given its shares fresh momentum, helping drive a one-day share price return of 1.39% and pushing its year-to-date share price return to 20.77%. Encouraged by growing...

NextNRG Inc. announced it would report its third quarter 2025 earnings on November 14, 2025, giving investors a key update on operational progress and financial performance. This scheduled release comes as market participants seek more insight into the company's expanding integrated energy offerings and increasing project pipeline. With the Q3 results now released, we'll examine how expectations for improved operational metrics and business scale could influence NextNRG's investment...

CRH (NYSE:CRH) just released its third quarter results, reporting gains in both revenue and net income compared to last year. The company also increased its quarterly dividend and completed a large share buyback. See our latest analysis for CRH. CRH’s latest quarterly update, with double-digit net income growth and a bigger dividend, arrives after a year of robust share price momentum. The stock is now up nearly 20% so far in 2025. Long-term holders have seen the real rewards as well, with a...

Equifax (EFX) has rolled out a new set of AI-powered anti-money laundering compliance solutions tailored for financial institutions. The platform combines machine learning with comprehensive global list screening to help firms manage growing regulatory requirements more effectively and efficiently. See our latest analysis for Equifax. The launch of Equifax’s new AI-driven compliance platform comes at a time when its stock has seen some pressure, with a recent 1-year total shareholder return...

Corteva (CTVA) delivered upbeat third quarter results and boosted its full-year outlook, with management now expecting both sales and earnings growth for 2025. The company also detailed plans to spin off its seeds business in 2026, marking a major transformation. See our latest analysis for Corteva. Corteva's upbeat earnings, new product launches, and plans for a seeds business spin-off have powered a notable recovery in sentiment, helping drive a 17.5% share price return year-to-date. While...

Wondering if Reddit stock is truly a bargain or just getting swept up in the buzz? You are not alone, as plenty of investors are debating its real value right now. In the past year, Reddit shares have jumped 43.6%. Even in the last week alone, the stock moved up 3.1%, hinting at lots of shifting sentiment and growth potential. News of Reddit expanding partnerships with AI companies and rolling out new ad formats has fueled the stock’s momentum. Investors hope these moves will unlock more...

DO & CO Aktiengesellschaft has released its second quarter and half-year results for 2025, reporting sales of €625.12 million and net income of €26.66 million for the quarter ended September 30, both up from the same period last year. Notably, the company's basic earnings per share from continuing operations rose to €4.87 for the first half of 2025, highlighting steady profit growth. With continued earnings and sales growth driving attention, we'll explore how this financial momentum shapes...

Earlier this week, Alnylam Pharmaceuticals announced and presented new post hoc analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), revealing amyloid regression in 22% of treated patients and preservation of kidney function, with a consistent safety profile demonstrated among those with advanced chronic kidney disease. This reinforces AMVUTTRA’s established efficacy as a multi-organ RNAi therapeutic, potentially highlighting its differentiation in treating...

In recent days, several law firms announced the filing of class action lawsuits against Telix Pharmaceuticals, alleging the company made false and misleading statements about its progress developing prostate cancer therapies and the strength of its supply chain between February 21, 2025 and August 28, 2025. This legal action brings heightened scrutiny to Telix’s disclosures and may influence how investors assess the company’s transparency and governance practices going forward. We'll explore...

eXp World Holdings reported third quarter 2025 results showing a return to profitability with net income of US$3.5 million, 7% year-over-year revenue growth to US$1.32 billion, and declared a US$0.05 per share dividend for the fourth quarter, payable December 1, 2025. The company also introduced its AI-powered business assistant, Mira, and continued expanding both its international presence and agent network, signaling a focus on technology and global growth drivers. We'll examine how eXp's...

Joby Aviation and L3Harris Technologies recently completed the first flight of Joby’s hybrid-electric, autonomous vertical takeoff and landing demonstrator, targeting both defense and future commercial applications. This milestone marks Joby Aviation’s entry into hybrid powertrain technology, expanding its platform beyond all-electric air taxis and opening new opportunities in military logistics and extended-range air mobility. Let’s explore how this hybrid demonstrator milestone reshapes...

LifeTech Scientific (SEHK:1302) has received official approval from the China National Medical Products Administration for its G-BranchTM thoracoabdominal artery stent graft system. This marks a major regulatory milestone for the company and its medical device portfolio. See our latest analysis for LifeTech Scientific. Even with this breakthrough regulatory approval, LifeTech Scientific’s stock has experienced some choppiness in recent months. While the 1-year total shareholder return sits at...

TTM Technologies recently reported that from July 1, 2025 to September 29, 2025, it did not repurchase any shares under its buyback program announced in May 2025, while management outlined expansion plans for advanced PCB manufacturing in China and a renewed focus on higher value-added segments during a non-deal roadshow. This renewed operational focus aligns with growing investor interest in value-oriented technology companies, particularly as industry caution mounts regarding...

Avadel Pharmaceuticals (AVDL) just announced third quarter and nine-month earnings results, showing a move from net losses to net income in both periods compared to last year. This jump highlights ongoing financial improvement and hints at a meaningful turnaround for the company. See our latest analysis for Avadel Pharmaceuticals. Shares of Avadel Pharmaceuticals have steadily gathered momentum in recent months, with a 30-day share price return of nearly 34% and a striking year-to-date gain...

Hamburger Hafen und Logistik (XTRA:HHFA) just released its third-quarter earnings, showing higher sales and net income compared to last year. The company reported growth in both the recent quarter and the year-to-date periods. See our latest analysis for Hamburger Hafen und Logistik. After a year of steady progress, Hamburger Hafen und Logistik’s recent results have given investors an added boost of confidence. The stock’s 21% share price return so far this year hints at mounting momentum. A...